Bond Screener
GSK PLC
LEI 5493000HZTVUYLO1D793
Organization name
GSK PLC
Country name
United Kingdom
Country of registration
United Kingdom
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
25,540 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
|
General information
-
Organization nameGSK PLC
-
Organization statusOperating organization
-
Address980 Great West Road Brentford, United Kingdom, TW8 9GS
-
Site
-
IR Site
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameGSK PLC
-
Organization statusOperating organization
-
Address980 Great West Road Brentford, United Kingdom, TW8 9GS
-
Site
-
IR Site
Codes
-
LEI5493000HZTVUYLO1D793
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0001131399
